Eli Lilly stock: LLY closes at $1,040 as $1.5 billion pill stockpile comes into focus
Eli Lilly closed Friday up 0.3% at $1,040 after disclosing $1.5 billion in pre-launch inventory for its experimental obesity pill, orforglipron. The company expects an FDA decision in April, using a priority voucher that could speed approval. U.S. markets are closed Monday for Washington’s Birthday. Trading resumes Tuesday.